Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant HPV Nonavalent Vaccine (E.Coli) in Healthy Population Aged 9-26
NCT05056402Phase 3Active, not recruiting
- Sponsor
- Xiamen University
- Start
- Sep 2021
- Primary completion
- Dec 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Cecolin 9 in Cervical Cancer (CC), condylomata acuminata, sponsored by Xiamen University. Started Sep 2021; status: active, not recruiting.
02
Drugs
Cecolin 9
03
Conditions
Cervical Cancer (CC)condylomata acuminata
Beyond the preview
Go deeper on NCT05056402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05056402.